Vienna, Austria - One of the largest studies to date looking at the impact of stent thrombosis and its treatment suggests that once thrombosis occurs, it matters very little whether the culprit was a ...

Intraprocedural stent thrombosis is a relatively rare complication of percutaneous coronary intervention (PCI) in patients with acute coronary syndromes (ACS), occurring less than 1% of of the time, ...

Please provide your email address to receive an email when new articles are posted on . PCI for in-stent chronic total occlusion had similar success rates and in-hospital complications compared with ...

In patients with three-vessel and/or left main coronary artery disease (CAD), percutaneous coronary intervention (PCI) with paclitaxel-eluting stents is equivalent to coronary artery bypass grafting ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window For percutaneous ...

(HealthDay News) — For patients with multivessel coronary artery disease, percutaneous coronary intervention (PCI) with everolimus-eluting stents is linked to increased cardiovascular events vs.

At 1 year, women experienced similar target lesion failure and ischemic outcomes compared with men after PCI with a dual-therapy stent, according to research published in Catheterization and ...

Although a relatively low rate of early stent thrombosis (within 30 days) can be achieved after primary PCI in real-world practice, there are signs that focusing on stent deployment and ...

A study, published in The New England Journal of Medicine, compared drug-eluting bioresorbable vascular scaffolds with drug-eluting metallic stents in percutaneous coronary interventions. Abbott ...